Multiple myeloma

Multiple myeloma appears in the evidence as a possible hematologic complication in transplant recipients with Hepatitis C infection. Its significance lies not in an established causal relationship, but in the way registry data place the malignancy within a broader pattern of post-transplant neoplasia requiring clinical surveillance.

Occurrence After Transplantation

A large American transplant registry comprising more than 66,000 recipients recorded 160 cases of Multiple myeloma, representing 0.24% of the transplant population. Hepatitis C infection was more prevalent among the recipients who developed myeloma than in the registry population overall, suggesting a possible association between chronic viral infection and this hematologic malignancy.

Evidence and Uncertainty

The registry observation was presented as an early indication rather than definitive proof. The data suggested, for the first time, that Hepatitis C infection might contribute to the pathogenesis of Multiple myeloma after transplantation, but the available analyses could not establish causation. The proposed relationship therefore remains epidemiologic and provisional, dependent on confirmation in additional studies.

Place Within Post-Transplant Risk

Multiple myeloma was discussed alongside post-transplant lymphoproliferative disorder and other hematologic neoplasias in the context of immunosuppressed allograft recipients. In the same body of evidence, malignancy was reported as the third leading cause of death among anti-HCV-positive recipients in Australia and New Zealand, exceeding deaths attributed to liver disease. These findings broaden the clinical concern beyond hepatic injury: transplant recipients with Hepatitis C may require attention to malignant disease as well as viral, liver, and graft-related complications.

Clinical Significance

Because the association between Hepatitis C infection and Multiple myeloma has not been definitively validated, the evidence supports close clinical surveillance rather than a disease-specific causal conclusion. Multiple myeloma consequently functions in this literature as a warning signal within the post-transplant risk profile: uncommon, potentially consequential, and associated with Hepatitis C in registry observations, but still requiring further investigation before its mechanism or independent risk can be defined.